Skip to main content
Clinical Trials/JPRN-UMIN000029995
JPRN-UMIN000029995
Completed
未知

Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysis - NCCH-1608

ational Cancer CEnter0 sites200 target enrollmentNovember 16, 2017
Conditionsung Cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
ung Cancer
Sponsor
ational Cancer CEnter
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 16, 2017
End Date
June 26, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Cancer CEnter

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not applicable

Outcomes

Primary Outcomes

Not specified

Similar Trials